An institutional holder
Filed with the SEC on · accession 0001104659-26-096807
KALV filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. An institutional holder filed an amended Schedule 13G for KalVista Pharmaceuticals, indicating a change in its passive ownership position.
An institutional holder filed an amended Schedule 13G for KalVista Pharmaceuticals, indicating a change in its passive ownership position. The filing text provided does not disclose the specific holder, share count, or percentage owned.
✦ Ask GOAX AI about this filing — what it means for KALV, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for KALV?
Click hereKALV filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for KalVista Pharmaceuticals, indicating a change in its passive ownership position. The filing text provided does not disclose the specific holder, share count, or percentage owned.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Get alerts when KALV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days